{"id":"NCT00747344","sponsor":"Centocor, Inc.","briefTitle":"A Phase 3 Trial to Look at the Safety and Effectiveness of Ustekinumab in Korean and Taiwanese Subjects With Moderate to Severe Plaque-type Psoriasis","officialTitle":"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Ustekinumab in the Treatment of Korean and Taiwanese Subjects With Moderate to Severe Plaque-type Psoriasis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-12","primaryCompletion":"2009-09","completion":"2010-03","firstPosted":"2008-09-05","resultsPosted":"2012-10-05","lastUpdate":"2013-03-29"},"enrollment":121,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Psoriasis"],"interventions":[{"type":"DRUG","name":"Placebo - Controlled Period (CP)","otherNames":[]},{"type":"DRUG","name":"Ustekinumab 45 mg - CP","otherNames":[]},{"type":"DRUG","name":"Placebo to ustekinumab 45 mg - after CP","otherNames":[]},{"type":"DRUG","name":"Ustekinumab 45 mg - after CP","otherNames":[]}],"arms":[{"label":"Placebo - Controlled Period (CP)","type":"PLACEBO_COMPARATOR"},{"label":"Ustekinumab 45 mg - CP","type":"EXPERIMENTAL"},{"label":"Placebo to ustekinumab 45 mg - after CP","type":"EXPERIMENTAL"},{"label":"Ustekinumab 45 mg - after CP","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of Ustekinumab in the treatment of patients with moderate to severe psoriasis in South Korea and Taiwan.","primaryOutcome":{"measure":"The Number of Patients Who Achieved at Least a 75% Improvement in PASI (Psoriasis Area and Severity Index) at Week 12","timeFrame":"Week 12","effectByArm":[{"arm":"Placebo","deltaMin":3,"sd":null},{"arm":"Ustekinumab 45 mg","deltaMin":41,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":7},"locations":{"siteCount":5,"countries":["South Korea","Taiwan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":60},"commonTop":["Pruritus","Upper respiratory tract infection","Nasopharyngitis","Hyperglycaemia","Psoriasis"]}}